the plasma fibrinogen and plasminogen concentrations decreased in all patients receiving apsac 30u , which indicates that apsac at this dose is not sufficiently fibrin-specific to dissolve thrombi without producing a lytic state .
C0032105
plasma
C0015982
fibrin